Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1984 2
1985 2
1987 2
1988 1
1989 1
1990 1
1996 2
1997 1
1998 3
1999 2
2001 1
2003 1
2004 1
2007 3
2008 7
2009 8
2010 8
2011 4
2012 16
2013 16
2014 18
2015 20
2016 19
2017 15
2018 20
2019 17
2020 14
2021 12
2022 15
2023 14
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Advances in the treatment of the muscular dystrophies.
Wood C, Robertson NP. Wood C, et al. Among authors: robertson np. J Neurol. 2024 Jul;271(7):4724-4726. doi: 10.1007/s00415-024-12493-z. Epub 2024 Jun 20. J Neurol. 2024. PMID: 38900296 No abstract available.
Diagnostic criteria for MOGAD.
Voase S, Robertson NP. Voase S, et al. Among authors: robertson np. J Neurol. 2024 Jun;271(6):3690-3692. doi: 10.1007/s00415-024-12405-1. Epub 2024 May 17. J Neurol. 2024. PMID: 38758280 Free PMC article. No abstract available.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N, Ford HL, Galea I, George S, Gray OM, Hibbert AM, Hu M, Hughes SE, Ingram G, Kalra S, Lim CE, Mathews JTM, McDonnell GV, Mescall N, Norris S, Ramsay SJ, Rice CM, Russell MJ, Shawe-Taylor MJ, Williams TE, Harding KE, Robertson NP. Tallantyre EC, et al. Among authors: robertson np. Eur J Neurol. 2024 Jul;31(7):e16289. doi: 10.1111/ene.16289. Epub 2024 Apr 3. Eur J Neurol. 2024. PMID: 38567516
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort.
Uzochukwu EC, Harding KE, Hrastelj J, Kreft KL, Holmans P, Robertson NP, Tallantyre EC, Lawton M. Uzochukwu EC, et al. Among authors: robertson np. Neuroepidemiology. 2024;58(3):218-226. doi: 10.1159/000536427. Epub 2024 Feb 20. Neuroepidemiology. 2024. PMID: 38377969 Free PMC article.
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP, Zelek WM, Tallantyre EC. Kodosaki E, et al. Among authors: robertson np. J Neuroinflammation. 2024 Feb 17;21(1):52. doi: 10.1186/s12974-024-03036-4. J Neuroinflammation. 2024. PMID: 38368354 Free PMC article.
Prodromal multiple sclerosis: considerations and future utility.
Harding KE, Kreft KL, Ben-Shlomo Y, Robertson NP. Harding KE, et al. Among authors: robertson np. J Neurol. 2024 Apr;271(4):2129-2140. doi: 10.1007/s00415-023-12173-4. Epub 2024 Feb 11. J Neurol. 2024. PMID: 38341810 Free PMC article. Review.
Cavernomas: to treat or not to treat?
Voase S, Robertson NP. Voase S, et al. Among authors: robertson np. J Neurol. 2024 Jan;271(1):618-620. doi: 10.1007/s00415-023-12115-0. Epub 2023 Dec 14. J Neurol. 2024. PMID: 38095721 Free PMC article. No abstract available.
232 results